{"id":686065,"date":"2022-09-15T23:29:03","date_gmt":"2022-09-16T03:29:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/"},"modified":"2022-09-15T23:29:03","modified_gmt":"2022-09-16T03:29:03","slug":"shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/","title":{"rendered":"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n NEW YORK<\/span>
\n <\/span>, Sept. 15, 2022<\/span><\/span> \/PRNewswire\/ — Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Syros Pharmaceuticals, Inc. (NASDAQ: SYRS).<\/p>\n

If you are a shareholder of Syros Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:<\/p>\n

\n http:\/\/pjlfirm.com\/syros-pharmaceuticals-inc\/<\/a>\n <\/p>\n

You may also contact Robert H. Lefkowitz, Esq.<\/span> either via email at rl@pjlfirm.com<\/a> or by telephone at 212-725-1000.\u00a0 One of our attorneys will personally speak with you about the case at no cost or obligation.<\/p>\n

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit http:\/\/pjlfirm.com<\/a>.\u00a0\u00a0 Attorney advertising. Prior results do not guarantee a similar outcome.\u00a0<\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/shareholder-alert-purcell–lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors-301625959.html<\/a><\/p>\n

SOURCE Purcell & Lefkowitz LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK , Sept. 15, 2022 \/PRNewswire\/ — Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Syros Pharmaceuticals, Inc. (NASDAQ: SYRS). If you are a shareholder of Syros Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: http:\/\/pjlfirm.com\/syros-pharmaceuticals-inc\/ You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.\u00a0 One of our attorneys will personally speak with you about the case at no cost or obligation. Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide … <\/p>\n

Continue reading “SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-686065","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Sept. 15, 2022 \/PRNewswire\/ — Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Syros Pharmaceuticals, Inc. (NASDAQ: SYRS). If you are a shareholder of Syros Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: http:\/\/pjlfirm.com\/syros-pharmaceuticals-inc\/ You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.\u00a0 One of our attorneys will personally speak with you about the case at no cost or obligation. Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide … Continue reading "SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-16T03:29:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC75213&sd=2022-09-15\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors\",\"datePublished\":\"2022-09-16T03:29:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/\"},\"wordCount\":200,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC75213&sd=2022-09-15\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/\",\"name\":\"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC75213&sd=2022-09-15\",\"datePublished\":\"2022-09-16T03:29:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC75213&sd=2022-09-15\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC75213&sd=2022-09-15\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Market Newsdesk","og_description":"PR Newswire NEW YORK , Sept. 15, 2022 \/PRNewswire\/ — Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Syros Pharmaceuticals, Inc. (NASDAQ: SYRS). If you are a shareholder of Syros Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: http:\/\/pjlfirm.com\/syros-pharmaceuticals-inc\/ You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.\u00a0 One of our attorneys will personally speak with you about the case at no cost or obligation. Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide … Continue reading \"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-16T03:29:03+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC75213&sd=2022-09-15","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors","datePublished":"2022-09-16T03:29:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/"},"wordCount":200,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC75213&sd=2022-09-15","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/","name":"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC75213&sd=2022-09-15","datePublished":"2022-09-16T03:29:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC75213&sd=2022-09-15","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC75213&sd=2022-09-15"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-purcell-lefkowitz-llp-is-investigating-syros-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/686065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=686065"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/686065\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=686065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=686065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=686065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}